Literature DB >> 3146754

Lipoproteins and apolipoproteins in postmortem serum.

C A Hornick1, H N Baker, G T Malcom, W P Newman, P S Roheim, J P Strong.   

Abstract

In order to correlate lipoprotein and apolipoprotein profiles with atherosclerotic lesions at autopsy, the feasibility of using postmortem serum in these determinations was evaluated. Lipoprotein and apolipoprotein profiles in dogs and monkeys were compared in pre- and postmortem serum samples, and it was found that, up to 24 h postmortem, no appreciable differences were observed in apolipoprotein A-I, B, E, and A-IV serum concentration when compared to premortem values. Electrophoretic mobilities and apolipoprotein gradient gel immunoblotting also revealed no differences in apolipoprotein size distribution. We conclude that postmortem sampling up to 24 h can be used effectively to approximate premortem lipoprotein and apolipoprotein profiles provided that careful sampling techniques are observed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3146754

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  1 in total

1.  n-3 long-chain FA decrease serum levels of TG and remnant-like particle-cholesterol in humans.

Authors:  Kei Hamazaki; Miho Itomura; Mingming Huan; Hiroto Nishizawa; Shiro Watanabe; Tomohito Hamazaki; Shigeki Sawazaki; Katsutoshi Terasawa; Shuuji Nakajima; Takashi Terano; Yoshiya Hata; Seiichi Fujishiro
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.